Professional
Added to YB: 2024-09-24
Pitch date: 2024-06-30
TFX [neutral]
Teleflex Incorporated
-45.38%
current return
Author Info
No bio for this author
Company Info
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
Market Cap
$5.1B
Pitch Price
$210.61
Price Target
N/A
Dividend
1.18%
EV/EBITDA
8.30
P/E
-15.90
EV/Sales
2.39
Sector
Health Care Equipment and Supplies
Category
value
Janus Henderson Contrarian Fund Portfolio Holding: Teleflex Incorporated
TFX: Underperformed despite in-line earnings. UroLift sales underwhelming post-Covid. Conservative 2024 guidance due to recent acquisitions. Attractive valuation with undervalued long-term growth prospects. Monitoring capital allocation for M&A and share repurchases.
Read full article (1 min)